Familial Adenomatous Polyposis Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 63 pages | ID: F7AF8E9A9DCCEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Familial Adenomatous Polyposis Treatment in Global, including the following market information:

Global Familial Adenomatous Polyposis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Familial Adenomatous Polyposis Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Icosapent Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Familial Adenomatous Polyposis Treatment include Cancer Prevention Pharmaceuticals Inc, Marina Biotech Inc and Thetis Pharmaceuticals LLC, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Familial Adenomatous Polyposis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Familial Adenomatous Polyposis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Familial Adenomatous Polyposis Treatment Market Segment Percentages, by Type, 2021 (%)

• Icosapent
• Eflornithine Hydrochloride
• Aspirin
• CEQ-508
• Others

Global Familial Adenomatous Polyposis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Familial Adenomatous Polyposis Treatment Market Segment Percentages, by Application, 2021 (%)

• Clinic
• Hospital
• Others

Global Familial Adenomatous Polyposis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Familial Adenomatous Polyposis Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Familial Adenomatous Polyposis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Familial Adenomatous Polyposis Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Cancer Prevention Pharmaceuticals Inc
• Marina Biotech Inc
• Thetis Pharmaceuticals LLC

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Familial Adenomatous Polyposis Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Familial Adenomatous Polyposis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL FAMILIAL ADENOMATOUS POLYPOSIS TREATMENT OVERALL MARKET SIZE

2.1 Global Familial Adenomatous Polyposis Treatment Market Size: 2021 VS 2028
2.2 Global Familial Adenomatous Polyposis Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Familial Adenomatous Polyposis Treatment Players in Global Market
3.2 Top Global Familial Adenomatous Polyposis Treatment Companies Ranked by Revenue
3.3 Global Familial Adenomatous Polyposis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Familial Adenomatous Polyposis Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Familial Adenomatous Polyposis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Familial Adenomatous Polyposis Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Familial Adenomatous Polyposis Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Familial Adenomatous Polyposis Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Familial Adenomatous Polyposis Treatment Market Size Markets, 2021 & 2028
  4.1.2 Icosapent
  4.1.3 Eflornithine Hydrochloride
  4.1.4 Aspirin
  4.1.5 CEQ-508
  4.1.6 Others
4.2 By Type - Global Familial Adenomatous Polyposis Treatment Revenue & Forecasts
  4.2.1 By Type - Global Familial Adenomatous Polyposis Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Familial Adenomatous Polyposis Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Familial Adenomatous Polyposis Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Familial Adenomatous Polyposis Treatment Market Size, 2021 & 2028
  5.1.2 Clinic
  5.1.3 Hospital
  5.1.4 Others
5.2 By Application - Global Familial Adenomatous Polyposis Treatment Revenue & Forecasts
  5.2.1 By Application - Global Familial Adenomatous Polyposis Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Familial Adenomatous Polyposis Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Familial Adenomatous Polyposis Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Familial Adenomatous Polyposis Treatment Market Size, 2021 & 2028
6.2 By Region - Global Familial Adenomatous Polyposis Treatment Revenue & Forecasts
  6.2.1 By Region - Global Familial Adenomatous Polyposis Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Familial Adenomatous Polyposis Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Familial Adenomatous Polyposis Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Familial Adenomatous Polyposis Treatment Revenue, 2017-2028
  6.3.2 US Familial Adenomatous Polyposis Treatment Market Size, 2017-2028
  6.3.3 Canada Familial Adenomatous Polyposis Treatment Market Size, 2017-2028
  6.3.4 Mexico Familial Adenomatous Polyposis Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Familial Adenomatous Polyposis Treatment Revenue, 2017-2028
  6.4.2 Germany Familial Adenomatous Polyposis Treatment Market Size, 2017-2028
  6.4.3 France Familial Adenomatous Polyposis Treatment Market Size, 2017-2028
  6.4.4 U.K. Familial Adenomatous Polyposis Treatment Market Size, 2017-2028
  6.4.5 Italy Familial Adenomatous Polyposis Treatment Market Size, 2017-2028
  6.4.6 Russia Familial Adenomatous Polyposis Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Familial Adenomatous Polyposis Treatment Market Size, 2017-2028
  6.4.8 Benelux Familial Adenomatous Polyposis Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Familial Adenomatous Polyposis Treatment Revenue, 2017-2028
  6.5.2 China Familial Adenomatous Polyposis Treatment Market Size, 2017-2028
  6.5.3 Japan Familial Adenomatous Polyposis Treatment Market Size, 2017-2028
  6.5.4 South Korea Familial Adenomatous Polyposis Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Familial Adenomatous Polyposis Treatment Market Size, 2017-2028
  6.5.6 India Familial Adenomatous Polyposis Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Familial Adenomatous Polyposis Treatment Revenue, 2017-2028
  6.6.2 Brazil Familial Adenomatous Polyposis Treatment Market Size, 2017-2028
  6.6.3 Argentina Familial Adenomatous Polyposis Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Familial Adenomatous Polyposis Treatment Revenue, 2017-2028
  6.7.2 Turkey Familial Adenomatous Polyposis Treatment Market Size, 2017-2028
  6.7.3 Israel Familial Adenomatous Polyposis Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Familial Adenomatous Polyposis Treatment Market Size, 2017-2028
  6.7.5 UAE Familial Adenomatous Polyposis Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Cancer Prevention Pharmaceuticals Inc
  7.1.1 Cancer Prevention Pharmaceuticals Inc Corporate Summary
  7.1.2 Cancer Prevention Pharmaceuticals Inc Business Overview
  7.1.3 Cancer Prevention Pharmaceuticals Inc Familial Adenomatous Polyposis Treatment Major Product Offerings
  7.1.4 Cancer Prevention Pharmaceuticals Inc Familial Adenomatous Polyposis Treatment Revenue in Global Market (2017-2022)
  7.1.5 Cancer Prevention Pharmaceuticals Inc Key News
7.2 Marina Biotech Inc
  7.2.1 Marina Biotech Inc Corporate Summary
  7.2.2 Marina Biotech Inc Business Overview
  7.2.3 Marina Biotech Inc Familial Adenomatous Polyposis Treatment Major Product Offerings
  7.2.4 Marina Biotech Inc Familial Adenomatous Polyposis Treatment Revenue in Global Market (2017-2022)
  7.2.5 Marina Biotech Inc Key News
7.3 Thetis Pharmaceuticals LLC
  7.3.1 Thetis Pharmaceuticals LLC Corporate Summary
  7.3.2 Thetis Pharmaceuticals LLC Business Overview
  7.3.3 Thetis Pharmaceuticals LLC Familial Adenomatous Polyposis Treatment Major Product Offerings
  7.3.4 Thetis Pharmaceuticals LLC Familial Adenomatous Polyposis Treatment Revenue in Global Market (2017-2022)
  7.3.5 Thetis Pharmaceuticals LLC Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Familial Adenomatous Polyposis Treatment Market Opportunities & Trends in Global Market
Table 2. Familial Adenomatous Polyposis Treatment Market Drivers in Global Market
Table 3. Familial Adenomatous Polyposis Treatment Market Restraints in Global Market
Table 4. Key Players of Familial Adenomatous Polyposis Treatment in Global Market
Table 5. Top Familial Adenomatous Polyposis Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Familial Adenomatous Polyposis Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Familial Adenomatous Polyposis Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Familial Adenomatous Polyposis Treatment Product Type
Table 9. List of Global Tier 1 Familial Adenomatous Polyposis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Familial Adenomatous Polyposis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Familial Adenomatous Polyposis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Familial Adenomatous Polyposis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Familial Adenomatous Polyposis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Familial Adenomatous Polyposis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Familial Adenomatous Polyposis Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Familial Adenomatous Polyposis Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Cancer Prevention Pharmaceuticals Inc Corporate Summary
Table 31. Cancer Prevention Pharmaceuticals Inc Familial Adenomatous Polyposis Treatment Product Offerings
Table 32. Cancer Prevention Pharmaceuticals Inc Familial Adenomatous Polyposis Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Marina Biotech Inc Corporate Summary
Table 34. Marina Biotech Inc Familial Adenomatous Polyposis Treatment Product Offerings
Table 35. Marina Biotech Inc Familial Adenomatous Polyposis Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Thetis Pharmaceuticals LLC Corporate Summary
Table 37. Thetis Pharmaceuticals LLC Familial Adenomatous Polyposis Treatment Product Offerings
Table 38. Thetis Pharmaceuticals LLC Familial Adenomatous Polyposis Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Familial Adenomatous Polyposis Treatment Segment by Type in 2021
Figure 2. Familial Adenomatous Polyposis Treatment Segment by Application in 2021
Figure 3. Global Familial Adenomatous Polyposis Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Familial Adenomatous Polyposis Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Familial Adenomatous Polyposis Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Familial Adenomatous Polyposis Treatment Revenue in 2021
Figure 8. By Type - Global Familial Adenomatous Polyposis Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Familial Adenomatous Polyposis Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Familial Adenomatous Polyposis Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Familial Adenomatous Polyposis Treatment Revenue Market Share, 2017-2028
Figure 12. US Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Familial Adenomatous Polyposis Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Familial Adenomatous Polyposis Treatment Revenue Market Share, 2017-2028
Figure 24. China Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Familial Adenomatous Polyposis Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Familial Adenomatous Polyposis Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Familial Adenomatous Polyposis Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Cancer Prevention Pharmaceuticals Inc Familial Adenomatous Polyposis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Marina Biotech Inc Familial Adenomatous Polyposis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Thetis Pharmaceuticals LLC Familial Adenomatous Polyposis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)